Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment-Reference-Cited by-同舟云学术

Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment

Published:2016-09-19 Issue:5 Volume:30 Page:441-451
ISSN:1173-8804
Container-title:BioDrugs
language:en
Short-container-title:BioDrugs

Author:

Gerber Simon,Gaida Annette,Spiegl Nicole,Wymann Sandra,Antunes Adriano Marques,Menyawi Ibrahim El,Zurbriggen Brigitte,Hubsch Alphonse,Imboden Martin

Funder

CSL Behring AG

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s40259-016-0192-3.pdf

Reference28 articles.

1. Hartung HP, Mouthon L, Ahmed R, Jordan S, Laupland KB, Jolles S. Clinical applications of intravenous immunoglobulins (IVIg)—beyond immunodeficiencies and neurology. Clin Experiment Immunol. 2009;158(Suppl 1):23–33.

2. Baxley A, Akhtari M. Hematologic toxicities associated with intravenous immunoglobulin therapy. Int Immunopharmacol. 2011;11:1663–7.

3. Berger M. Adverse effects of IgG therapy. J Allergy Clin Immunol Pract. 2013;1:558–66.

4. Daw Z, Padmore R, Neurath D, Cober N, Tokessy M, Desjardins D, et al. Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis. Transfusion. 2008;48:1598–601.

5. Kahwaji J, Barker E, Pepkowitz S, Klapper E, Villicana R, Peng A, et al. Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients. Clin J Am Soc Nephrol. 2009;4:1993–7.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of the sensitized pediatric renal transplant candidate;Pediatric Transplantation;2024-02-24

2. A retrospective analysis of haemolytic reactions to intravenous immunoglobulin using data from the Transfusion‐Transmitted Injuries Surveillance System (Ontario);Vox Sanguinis;2023-08-17

3. Incidence and risk factors for intravenous immunoglobulin‐related hemolysis: A systematic review of clinical trial and real‐world populations;Transfusion;2022-08-02

4. Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2;Transfusion Medicine Reviews;2022-07

5. Hemolysis after high‐dose intravenous immunoglobulin: An under‐appreciated sequelae;American Journal of Hematology;2022-02-22